Novel Serine-Arginine Protein Kinase Inhibitors for Treating Cancer.
Rachel MataPublished in: ACS medicinal chemistry letters (2023)
Described herein are novel serine-arginine protein kinase (SRPK) inhibitors, their pharmaceutical compositions, the use of such compounds in treating cancer, and processes for preparing such compounds.